Evidence map›Paper›PMID 28605766›Full record

ArticleDatabase : the journal of biological databases and curation2017

GeneHancer: genome-wide integration of enhancers and target genes in GeneCards.

Simon Fishilevich, Ron Nudel, Noa Rappaport, Rotem Hadar, Inbar Plaschkes, Tsippi Iny Stein, Naomi Rosen, Asher Kohn, Michal Twik, Marilyn Safran and 2 more

Abstract read
In one paragraph

Article in Database : the journal of biological databases and curation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 811 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
811citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

811 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Associations ofBiomolecules · 2026
    Article
  12. Article
  13. Article
  14. UnlockingNAR genomics and bioinformatics · 2026
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

751 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Simon FishilevichDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.
Ron NudelDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.
Noa RappaportDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.
Rotem HadarDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.
Inbar PlaschkesDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.
Tsippi Iny SteinDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.
Naomi RosenDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.
Asher KohnLifeMap Sciences Inc, Marshfield, MA 02050, USA.
Michal TwikDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.
Marilyn SafranDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.
Doron LancetDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.
Dana CohenDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A major challenge in understanding gene regulation is the unequivocal identification of enhancer elements and uncovering their connections to genes. We present GeneHancer, a novel database of human enhancers and their inferred target genes, in the framework of GeneCards. First, we integrated a total of 434 000 reported enhancers from four different genome-wide databases: the Encyclopedia of DNA Elements (ENCODE), the Ensembl regulatory build, the functional annotation of the mammalian genome (FANTOM) project and the VISTA Enhancer Browser. Employing an integration algorithm that aims to remove redundancy, GeneHancer portrays 285 000 integrated candidate enhancers (covering 12.4% of the genome), 94 000 of which are derived from more than one source, and each assigned an annotation-derived confidence score. GeneHancer subsequently links enhancers to genes, using: tissue co-expression correlation between genes and enhancer RNAs, as well as enhancer-targeted transcription factor genes; expression quantitative trait loci for variants within enhancers; and capture Hi-C, a promoter-specific genome conformation assay. The individual scores based on each of these four methods, along with gene–enhancer genomic distances, form the basis for GeneHancer’s combinatorial likelihood-based scores for enhancer–gene pairing. Finally, we define ‘elite’ enhancer–gene relations reflecting both a high-likelihood enhancer definition and a strong enhancer–gene association. GeneHancer predictions are fully integrated in the widely used GeneCards Suite, whereby candidate enhancers and their annotations are displayed on every relevant GeneCard. This assists in the mapping of non-coding variants to enhancers, and via the linked genes, forms a basis for variant–phenotype interpretation of whole-genome sequences in health and disease. Database URL: http://www.genecards.org/.

Indexed as

Databases, Nucleic AcidEnhancer Elements, GeneticGenomeWeb BrowserGenome-Wide Association StudyPredictive Value of TestsSequence Analysis, DNA

Identifiers

PMID28605766
PMCPMC5467550

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.